Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Nature Reviews. Clinical Oncology|March 18, 2023
Neoadjuvant therapy for pancreatic cancerChristoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaAndrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Pharmaceutical Research|April 28, 2010
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerSanjeev Banerjee, Asfar S Azmi, Subhash Padhye, et al.
Plos One|March 17, 2011
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancerBin Bao, Shadan Ali, Dejuan Kong, et al.
ISRN Oncology|October 30, 2013
Radiographic parameters in predicting outcome of patients with hepatocellular carcinoma treated with yttrium-90 microsphere radioembolizationMohamed E Salem, Nitin Jain, Gregory Dyson, et al.
Pancreas|December 25, 2002
Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and CaucasiansNat L Pernick, Fazlul H Sarkar, Philip A Philip, et al.
Medical Oncology (Northwood, London, England)|October 24, 2009
Clinicopathological analysis of primary epithelial appendiceal neoplasmsSachin Gupta, Venkata Parsa, Volkan Adsay, et al.
Cancer|July 13, 2012
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trialsTodd M Bauer, Bassel F El-Rayes, Xiaobai Li, et al.
Cancer Metastasis Reviews|September 9, 2021
Targeting KRAS in pancreatic cancer: new drugs on the horizonSahar F Bannoura, Md Hafiz Uddin, Misako Nagasaka, et al.
Molecular Cancer Therapeutics|January 8, 2017
Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal AdenocarcinomaAmro Aboukameel, Irfana Muqbil, William Senapedis, et al.
Pageof 22